Applied Genetic Tech (AGTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | N/A | N/A | 820 |
| Receivables | N/A | N/A | N/A | N/A | 180 |
| Other current assets | 0 | 0 | 0 | 0 | 90 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $1,090 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 820 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 1,674 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $2,494 |
| Total Assets | $N/A | $N/A | $N/A | $N/A | $2,820 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 1,000 |
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 0 | 110 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 360 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $1,490 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 10 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 80 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $90 |
| Total Liabilities | $N/A | $N/A | $N/A | $N/A | $1,590 |
| Shareholders' Equity | |||||
| Retained earnings | N/A | N/A | N/A | N/A | -43,430 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 32,520 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $1,230 |
| Total Liabilities And Equity | $0 | $0 | $0 | $0 | $2,820 |